See also this year's filing and all EDGAR filings for this company.
PDF Report 0001343009_2023_CNBX_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001343009, CNBX Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 198,287 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 436,792 |
| 3 | remainder_Assets | 176,087 |
| 4 | LiabilitiesCurrent | 2,443,475 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,770,689 |
| 9 | ResearchAndDevelopmentExpense | 1,183,281 |
| 10 | remainder_Expenses | 782,080 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 12,800 |
| 13 | remainder_ComprehensiveNetIncome | -669,131 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 811,166 |
| 1 | Liabilities | 2,443,475 |
| 2 | Expenses | 3,736,050 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,632,309 |
| 5 | NetIncome | -3,723,250 |
| 6 | ComprehensiveNetIncome | -4,057,816 |
| 7 | BaseVar | 3,836,311 |
| 8 | EconomicCapitalRatio | -4.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
